Home › Trial NCT06735781
Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France
- Trial IDNCT06735781
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorBristol-Myers Squibb
- Enrollment101
- Start date2024-09-05
- ConditionsNon-small Cell Lung Cancer (NSCLC)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.